UPDATE: The Justice Department brief is now linked. ——– Six times in recent years — as recently as two weeks ago — the Supreme Court has refused to hear claims that it is illegal for a drug maker holding a patent on a brand-name medicine to pay the maker of a generic version to keep … Continue reading U.S.: Strong stand on pay-for-delay on drugs